We read with interest the Correspondence by Zhiqi Yao and colleagues1 published in The Lancet Diabetes & Endocrinology, which ...

Prediabetes is an important clinical concern. Not only is it a harbinger of future type 2 diabetes—with all the attendant ...

Neutralising monoclonal antibodies (NAbs) are being developed for future respiratory virus threats, notably highly pathogenic ...

Despite significant advances in early detection, surgery, radiotherapy, and systemic treatment of breast cancer, late relapse ...

Professor Sir Tumani Corrah is the Emeritus Director of the Medical Research Council (MRC) Unit The Gambia at the London ...

Countries have a legal obligation to combat climate change. The challenge for health is to make sure that they comply. Udani ...

On July 17, 2025, the US Food and Drug Administration (FDA) authorised marketing of five Juul e-cigarette products to adults, ...

Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...

In September, 2025, global stakeholders will convene at the United Nations General Assembly for the fourth High-Level Meeting ...

Every day, we are exposed to radiation—when going through security scanners, during routine medical care, or directly from the environment. In each case, our radiation safety limits are based on ...

Singapore’s Healthier SG initiative, as reviewed by Foo and colleagues,1 signals a transformative shift in national healthcare strategy—centred on prevention, continuity, and patient centred care.

Hepatocellular carcinoma remains a substantial global public health concern, disproportionately affecting low-income and middle-income countries, particularly in Africa.1 Its burden in Africa is ...